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Introduction: The primary objective of this study was to determine the efficiency of hydrogen peroxide (H2O2)
techniques in disinfection of ICU rooms contaminated with multidrug-resistant organisms (MDRO) after patient
discharge. Secondary objectives included comparison of the efficiency of a vaporizator (HPV, Bioquell®) and an
aerosolizer using H2O2, and peracetic acid (aHPP, Anios®) in MDRO environmental disinfection, and assessment of
toxicity of these techniques.
Methods: This prospective cross-over study was conducted in five medical and surgical ICUs located in one
University hospital, during a 12-week period. Routine terminal cleaning was followed by H2O2 disinfection. A total
of 24 environmental bacteriological samplings were collected per room, from eight frequently touched surfaces, at
three time-points: after patient discharge (T0), after terminal cleaning (T1) and after H2O2 disinfection (T2).
Results: In total 182 rooms were studied, including 89 (49%) disinfected with aHPP and 93 (51%) with HPV.
At T0, 15/182 (8%) rooms were contaminated with at least 1 MDRO (extended spectrum β–lactamase-producing
Gram-negative bacilli 50%, imipenem resistant Acinetobacter baumannii 29%, methicillin-resistant Staphylococcus
aureus 17%, and Pseudomonas aeruginosa resistant to ceftazidime or imipenem 4%). Routine terminal cleaning
reduced environmental bacterial load (P <0.001) without efficiency on MDRO (15/182 (8%) rooms at T0 versus 11/182
(6%) at T1; P = 0.371). H2O2 technologies were efficient for environmental MDRO decontamination (6% of rooms
contaminated with MDRO at T1 versus 0.5% at T2, P = 0.004). Patient characteristics were similar in aHPP and HPV
groups. No significant difference was found between aHPP and HPV regarding the rate of rooms contaminated with
MDRO at T2 (P = 0.313). 42% of room occupants were MDRO carriers. The highest rate of rooms contaminated with
MDRO was found in rooms where patients stayed for a longer period of time, and where a patient with MDRO was
hospitalized. The residual concentration of H2O2 appears to be higher using aHPP, compared with HPV.
Conclusions: H2O2 treatment is efficient in reducing MDRO contaminated rooms in the ICU. No significant difference
was found between aHPP and HPV regarding their disinfection efficiency.Introduction
Intensive care unit (ICU)-acquired infection is a com-
mon adverse event in critically ill patients [1]. This infec-
tion is frequently related to multidrug-resistant organisms
(MDRO), and is associated with high morbidity and
mortality rates [2]. Infections related to MDRO are fre-
quently associated with inappropriate initial antimicrobial* Correspondence: s-nseir@chru-lille.fr
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unless otherwise stated.treatment and an increased mortality rate [3]. Therefore,
the prevention of ICU-acquired infections related to
MDRO is a crucial issue.
The environment is a major reservoir for MDRO.
These organisms remain viable on various inanimate
surfaces for days to months [4,5]. Pathogens can then be
transferred from the environment to patients directly by
contact between patients and the contaminated environ-
ment and indirectly through healthcare workers’ (HCW)
hands. Environmental persistence of pathogens is also
thought to facilitate vertical transmission [6,7]. Admission
to a room previously occupied by a patient colonized or
infected with methicillin-resistant Staphylococcus aureustral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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tobacter baumannii, Pseudomonas aeruginosa or Clostrid-
ium difficile increases the risk of acquiring the same
organism by the subsequent patient admitted in the same
room [8-11].
Current every-day and terminal cleaning methods
seem to be microbiologically ineffective [12]. This fact is
generally under-recognized since environmental micro-
biological quality is rarely assessed. Hygiene failure is
partly due to HCW understaffing or over-workload,
hardly reachable surfaces, and ineffectiveness of com-
mon disinfectants against bacteria growing within bio-
film. Therefore, new automated disinfection methods are
being increasingly studied. Hydrogen peroxide (H2O2)
generators are the most investigated, including H2O2
aerosolization (aHP), and H2O2 vaporization (HPV) [6].
Previous studies demonstrated in vitro, in situ and
clinical effectiveness of H2O2 techniques in reducing en-
vironment contamination by MDRO [13-23]. However,
several limitations of these studies should be taken into
account, including the small number of studied ICU
rooms, the absence of systematic environmental samples
and the focus on specific MDRO or specific population.
Further, to our knowledge, no study has compared the
efficiency of an aerosolizer using H2O2 and peracetic
acid (aHPP), and HPV techniques.
The primary objective of this study was to determine the
efficiency of H2O2 techniques in disinfection of ICU rooms
contaminated with MDRO after patient discharge. Second-
ary objectives included comparison of the efficiency of an
HPV system (Bioquell®, Bonneuil sur Marne, France) and
an aHPP system (Anios®, Lille, France) combining H2O2
with acetic and peracetic acids in MDRO environmental
disinfection, and assessment of toxicity of these techniques.
Material and methods
Study design
This prospective cross-over study was performed dur-
ing a three-month period (April through June 2012)
in five medical and surgical ICUs located in the Uni-
versity Hospital of Lille, France. These units included
three 10-bed, one 12-bed, and one 4-bed units. All
rooms were single-bed. The study is in compliance
with the Helsinki Declaration. In accordance with the
French law, the study did not require an ethical ap-
proval. No informed consent was required by the
local Institutional Review Board (CPP Nord Ouest IV)
because of the non-interventional design of the study
upon patients.
The primary objective was to determine the efficiency
of H2O2, used after terminal cleaning, in reducing the
percentage of ICU rooms contaminated with MDRO.
Secondary objectives were to compare the efficiency of
HPV with aHPP in reducing the percentage of ICUrooms contaminated with MDRO and to compare the
residual concentration of H2O2 using these techniques.
Routine terminal cleaning was performed after patient
discharge and was followed by H2O2 disinfection. During
the first six-week period, two 10-bed units and the 4-bed
unit were disinfected by HPV and the 22 other rooms
were disinfected by aHPP. During the second six-week
period, H2O2 technologies were inverted. The order of
HPV, and aHPP in different units was randomized.
The French standard for the tested methods is a
microbiological in vitro test. Both methods passed these
tests. However, the current study is an in situ evaluation
using environmental sampling.
Environmental sampling
Twenty four microbiological samples were collected per
room at three time points: just after patient discharge
(T0), after terminal cleaning (T1) and after H2O2 disin-
fection (T2). Premoistened swabs were used to sample 5
cm2 of eight environmental surfaces: 1) inside the lateral
part of the mattress; on highly-touched surfaces of 2)
the ventilator; and 3) the monitor; 4) the underside of
the overbed table; 5) on the room door handle; 6)
around the sink; 7) on the keyboard for 13 computerized
rooms – in storage box for other rooms; and 8) on the
bedrails. In order to avoid sampling the same surface
area at different time points, the sampling area was adja-
cent at each sampling point.
The microbiologists were blinded to H2O2 technology.
Each swab was plated onto Columbia blood agar
(bioMérieux, La Balme les grottes, France). An enrich-
ment culture was made by discharging each swab into a
brain heart infusion (BHI) to be re-isolated onto
Columbia blood agar if positive. The plates and BHI
were incubated at 37°C for 48 hours. Each bacterial col-
ony was identified by MALDI-TOF mass spectrometry
(Microflex; Bruker Daltonics, Wissembourg, France).
The susceptibility of the target isolates was performed by
the disk diffusion method on Mueller-Hinton agar [24].
Standard cleaning practices
During ICU stay, the floor was cleaned three times a day
using a wet sweep and once a day using a quaternary
ammonium compound (Aniosurf®, Anios, Lille, France).
After patient discharge, HCW cleaned and disinfected
surfaces using Aniosurf®. Wipes were drenched into the
bucket of quaternary ammonium solution for 15 minutes
before use. Two applications were given. A five-minute
contact time was observed after each application. This
cleaning always followed the same sequence (from top to
bottom; from cleaner to dirtier). The sink was first cleaned
by a detergent (Deterg’anios®, Anios, Lille, France), rinsed
with clear water and then cleaned and disinfected with
Aniosurf®. After a wet sweep, floors were cleaned with
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with sodium hypochlorite solution (contact time: 15
minutes). Before starting the study, HCW were updated
concerning terminal cleaning good practices.HPV disinfection
After terminal cleaning, a manufacturer’s agent placed
an HPV and an H2O2 catalyzer into the room. Room
ventilation and door were sealed using tape. H2O2 con-
centration inside disinfected rooms was continuously
monitored. The generator converted 30% liquid H2O2
into vapor during about 15 minutes until the dew point.
After a 30-minute contact time, H2O2 was converted to
oxygen and water vapor by the catalyzer. The room was
opened when the inside H2O2 concentration was below
1 ppm, representing the safe permissible limit of H2O2.
The time required for the entire process was approxi-
mately 1 hour 40 minutes.aHPP disinfection
After terminal cleaning, HCW covered screen monitors,
and placed the aHPP machine in a corner of the room,
powered it on, and left the room. Sixty seconds later, aero-
solization of a 7% H2O2 solution associated with 0.25%
peracetic acid and 30% acetic acid began for 23 minutes
(suitable time for a 60 m3 room). After a 30-minute con-
tact time and then two hours of room ventilation, the
room was available. The time required for the entire
process was approximately 2 hours 54 minutes.Measurement of H2O2 concentration
H2O2 concentration was measured at the end of va-
porization/aerosolization in the corridor and rooms next
to the treated room and in the treated room at the end of
the entire process. H2O2 concentration was recorded by
two methods: an electronic one (Pac III®, Dräger) and a
chemical one (Dräger tubes® and Accuro® pump, Dräger,
Pittsburgh, PA, USA). For aHPP, acetic acid concentra-
tion was analyzed using a chemical process (Dräger
tubes® and Accuro® pump, Dräger).Clinical data
The characteristics of the room occupants were col-
lected, including MDRO status and ICU-length of stay.
MDRO were defined as MRSA, P. aeruginosa resistant
to ceftazidime or imipenem, extended spectrum β–lacta-
mase (ESBL)-producing Gram-negative bacilli (GNB),
imipenem resistant Acinetobacter baumannii (IRAB)
and VRE. During the study period, all ICU patients were
screened (nasal and anal swabs) for MDRO at ICU
admission and once a week.Statistical analyses
SAS software (9.3 version, SAS Institute Inc., Cary, NC
27513, USA) was used for data analysis. Based on the
prevalence of 30% to 40% of MDRO in our ICU, we esti-
mated an incidence of rooms contaminated with MDRO
after routine terminal cleaning (T1) of 20% and after
H2O2 treatment (T2) of 5%. Studying 76 rooms in each
group (aHPP and HPV) would allow detection of this
difference with an 80% power and a two-tailed signifi-
cance level of 0.05.
Results are presented as frequency (percentage) for
categorical variables and median (interquartile range) for
quantitative variables. The normality of distribution was
tested by a Shapiro Wilk test. To compare groups at dif-
ferent time points (T0, T1, T2), the chi-squared test or
Fisher’s exact test, and the Mann–Whitney U-test were
used for qualitative and quantitative variables, respect-
ively. All P values were two-tailed. The statistical signifi-
cance was defined as P <0.05.
Comparisons between T0 and T1, and T1 and T2 were
performed using McNemar’s test. In order to identify
rooms at higher risk for positivity for MDRO, rooms
were classified based on occupant status regarding
MDRO, and duration of ICU stay ≥8 days (median length
of ICU stay in study population).
Results
One hundred and eighty two rooms were studied, includ-
ing 93 (51%) disinfected with HPV and 89 (49%) with the
aHPP system (Figure 1). Occupancy rate was 90%.
Routine terminal cleaning and H2O2 efficiency
At T0, 141 out of 182 (77%) rooms were contaminated
with at least 1 bacterium and 15 (8%) with at least 1
MDRO (Table 1). Routine terminal cleaning was associ-
ated with a significant reduction of bacterial environmen-
tal contamination (P <0.001). However, no significant
difference was found in the percentage of MDRO contam-
inated rooms between T0 and T1. The percentage of
rooms contaminated with bacteria or with MDRO was
significantly lower at T2 compared with T1.
At T0, MDRO were mainly located near the sink. Re-
sults on the efficiency of terminal cleaning and H2O2
disinfection in reducing MDRO contamination of different
sites are presented in Table 2. At T0, ESBL-GNB were the
most frequently identified MDRO (50%) followed by IRAB
(29%), MRSA (17%) and MDR P. aeruginosa (4%). Only
one MDRO was identified per room at T0, except for one
room where two different ESBL-GNB were found. At T1,
four of the fourteen isolated MDRO were not identi-
fied at T0.
The percentage of microbiological samples positive for
MDRO was significantly lower at T1, compared with
T0 and at T2, compared with T1. The percentage of
Figure 1 Study flowchart. HPV, hydrogen peroxide vaporization; aHPP, aersolization of hydrogen peroxide.
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cantly lower at T2, compared with T1. No significant
difference was found in the rate of samples positive for
other MDRO between T2 and T1 (Table 3).Comparison of H2O2 technologies
The percentage of ICU rooms contaminated with
MDRO at T2 was similar in the HPV group compared
with the aHPP group (1 out of 51 (1.9%) versus 0 out of
49 (0%), P = 0.313). Before H2O2 disinfection, bacterial
and MDRO environmental contaminations were similar
in the two groups.Patient characteristics
Seventy four out of 177 (42%) room occupants (5 missing
data) were colonized or infected with MDRO, including
43 (24%) ESBL-GNB, 18 (10%) MDR P. aeruginosa, 15
(8%) MRSA and 11 (6%) IRAB. No VRE was identified
during the study period. Only one patient suffered from
Clostridium difficile-associated disease. At ICU admission,
MDRO were identified in 27 (15.2%) patients, including
10 (5.6%) ESBL, 8 (4.5%) P. aeruginosa, 6 (3.3%) MRSA
and 3 (1.6%) IRAB.
Median ICU length of stay was 8 days (4, 18). ICU
length of stay was significantly longer in rooms contami-
nated with MDRO compared with those not contami-
nated with MDRO (23 (15, 35) days versus 7 (4, 15)
days, P = 0.003). In rooms contaminated with MDRO at
T0, occupants were known as MDRO carriers in 10 out
of 15 (67%) cases compared with 5 out of 162 (3%) in
rooms where occupants were not colonized or infected
with MDRO, P <0.005.Table 1 Efficiency of terminal cleaning and H2O2 disinfection
T0 number = 182 T1 n
Rooms contaminated with at least one bacterium 141 (77) 70 (3
Rooms contaminated with at least one MDRO 15 (8) 11 (6
Data are numbers (%). MDRO, multidrug-resistant organism.The percentage of patients with MDRO was similar in
rooms disinfected using aHPP and those disinfected
using HPV (38/89 (44%) versus 36/93 (40%), respect-
ively, P = 0.731). The percentages of different MDRO
were also comparable in the two groups. ICU length of
stay was similar in aHPP and HPV groups (8 (4, 15) days
versus 8 (4, 18) days, respectively, P = 0.975).
Classification of ICU rooms based on patient MDRO status
and length of ICU stay
The percentage of rooms contaminated with MDRO was
significantly higher in rooms with length of ICU stay ≥8
days occupied by a patient with MDRO compared with
rooms with length of ICU stay <8 days where the prior
room occupant was not an MDRO carrier (10 out of 53
(19%) versus 2 out of 65 (3%), P = 0.012, odds ratio (OR)
(95% confidence interval (CI)) 7.3 (1.5, 35.1)) (Figure 2).
Toxicity
Four toxicity tests were performed in aHPP rooms and
five in HPV rooms. H2O2 and acetic acid were never
found in the corridor or in the rooms next to the studied
room during the process. At the end of the HPV
process, H2O2 concentrations inside tested rooms were
between 0.4 and 0.7 ppm. At the end of aHPP disinfec-
tion, the H2O2 rate ranged from 0.5 to >3 ppm inside
tested rooms; acetic acid was <5 ppm. Persons who en-
tered aHPP treated rooms described an unpleasant smell
and irritation of the eyes and upper airways.
Discussion
Our results suggest that routine terminal cleaning
followed by H2O2 treatment is more efficient than routineumber = 182 Δ T0-T1 P T2 number = 182 Δ T1-T2 P
8) - 39% <0.001 10 (5) - 33% <0.001
) - 2% 0.371 1 (0.5) - 5.5% 0.004
Table 2 MDRO contamination of different environmental
sites at different time points
Rooms contaminated








Mattress 1 (0.5) 1 (0.5) 0 (0)
Ventilator 3 (2) 0 (0) 0 (0)
Monitor 4 (2) 0 (0) 0 (0)
Overbed table 0 (0) 0 (0) 0 (0)
Room door handle 3 (2) 0 (0) 0 (0)
Sink 9 (5) 9 (5) 0 (0)
Keyboard (58 rooms) 0 (0) 0 (0) 0 (0)
Storage box
(124 rooms)
0 (0) 1 (0.8) 1 (0.8)
Bedrails 3 (2) 1 (0.5) 0 (0)
Data are numbers (%). MDRO, multidrug-resistant organisms.
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taminated ICU-rooms after patient discharge. No signifi-
cant difference was found between aHPP and HPV
regarding percentage of ICU rooms contaminated with
MDRO after terminal cleaning and disinfection using
these techniques. The residual concentration of H2O2 ap-
pears to be higher using aHPP compared with HPV.
Our study demonstrates a significant reduction in the
percentage of MDRO contaminated rooms using H2O2
techniques. The strength of this study is the large num-
ber of sequential environmental samples performed to
determine the efficiency of these techniques. Previous
studies demonstrated that HPV was an efficient tech-
nique to improve environmental disinfection after pa-
tient discharge [13-15,17-23]. This efficiency has been
demonstrated in vitro and in vivo during endemic and
epidemic periods. However, several limitations of these
studies should be outlined, including in vitro design,
small number of studied ICU rooms, absence of system-











MDRO 23 (1.5) 14 (0.96)* 2 (0.13)*
ESBL 12 (0.82) 14 (0.96) 2 (0.13)*
MRSA 4 (0.27) 0 (0) 0 (0)
IRAB 6 (0.41) 0 (0) 0 (0)
Resistant P.
aeruginosa
1 (0) 0 (0) 0 (0)
Data are numbers (%). ESBL, extended spectrum β-lactamase producing Gram
negative bacilli; IRAB, impipenem resistant Acinetobacter baumannii; MDRO,
multidrug-resistant organisms; MRSA, methicillin resistant Staphylococcus
aureus. *P = 0.004 versus T0, <0.001 versus T1, <0.001 versus T1, respectively.
P >0.2 for all other comparisons.or specific population. A recent observational clinical
study found environmental decontamination with HPV
to be associated with significantly reduced risk for pa-
tient acquisition of MDRO [16]. While the number of
sampled rooms was high (n = 1,039), environmental
samples were only performed at one time-point in a
small proportion of studied rooms (11.7%). In addition,
neither rooms nor units were randomly assigned to the
intervention.
Our study is the first to assess the efficiency of an
aHPP system using a solution containing H2O2 and
acetic and peracetic acids, and to compare it with HPV.
Several studies demonstrated the in vitro and in situ ef-
fectiveness of silver-based aHP in disinfecting inanimate
surfaces. The bacterial load reduction was incomplete
and has been proven for MRSA, VRE, A. baumannii, C.
difficile and geobacillus stearothermophilus biological in-
dicators [25-31]. However, the conclusions of these stud-
ies could not be applied to the aHPP technique using
acetic and peracetic acids. Two previous studies com-
pared HPV to an aHP treatment combining H2O2 with
silver cations [32,33]. Although these in vitro experi-
ments highlighted a greater reduction of bacterial load
with HPV, our study found similar efficiency of HPV and
aHPP. These results suggest that aHPP might be more
efficient than aHP. However, further studies directly
comparing these techniques are required to confirm this
hypothesis.
Terminal cleaning in France is probably different from
that performed in the USA or other parts of the world.
The major part of MDRO was isolated around the sink,
suggesting that cleaning of this area should be improved.
This improvement could be sufficient to reduce vertical
transmission of MDRO via room surfaces. However, pre-
vious studies have clearly shown that improvement in
terminal cleaning was not sufficient to control MDRO
transmission via surfaces [12]. H2O2 and peracetic acid
are powerful oxidants with bactericidal, fungicidal, spori-
cidal and virucidal effects. However, H2O2, acetic and
peracetic acids are corrosive and caustic, and are toxic
to human beings at high doses (>1 ppm, >10 ppm and
>0.17 ppm, respectively). Governments impose occupa-
tional exposure limits to chemical products. The H2O2
long-term exposure limit is 1 ppm/8 hours in several
countries (France, USA, UK). Our results suggest that
residual concentrations of H2O2 are higher using aHPP
compared with HPV. However, the small number of
tests performed to determine these concentrations pre-
clude definite conclusions regarding the toxicity of
aHPP. In addition, in the absence of data concerning
peracetic acid concentration, we cannot affirm the safety
of aHPP system.
In practice, H2O2 decontamination devices are associ-
ated with a longer waiting time between two subsequent
Figure 2 Classification of study rooms based on patient characteristics. LOS, length of stay; MDRO, multidrug-resistant organisms.
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minutes for HPV and 3 hours for aHPP. They are also
associated with increased hospital costs. One could
argue that these costs are counterbalanced by lower
costs related to ICU-acquired infections management.
However, cost-effectiveness analyses are required to con-
firm this hypothesis. In our experience, no alteration of
medical devices was observed. The Environmental Pro-
tection Agency (USA) has reported a medium-term
compatibility of HPV with various materials and elec-
tronic equipment [34].
In spite of a high rate of patients with MDRO (42%),
the percentage of ICU rooms contaminated with MDRO
at patient discharge was relatively low (8%). However,
this rate is in line with previously reported results
[17,21]. Three potential explanations could be given for
this result. First, the relatively short median length of
ICU stay (eight days) did not allow heavy contamination
of the environment with MDRO. Second, bacteriological
samples performed at patient discharge might have
missed the contaminated surfaces. However, eight swabs
were performed per room at T0, allowing examination
of the most frequently touched surfaces by the patient
and HCW. Third, our strict terminal cleaning protocol,
including the routine use of sodium hypochlorite solu-
tion might have contributed to this result. However, it is
unlikely that floor cleaning had an impact on the preva-
lence of MDRO contaminated rooms because all sampledareas were high touched surfaces unconnected to the
floor.
ICU rooms at the highest risk for contamination with
MDRO were those where patients stayed for a long
period of time (≥8 days), and where the prior room oc-
cupant was an MDRO carrier. This might be helpful to
apply a targeted strategy for disinfection of ICU rooms
using H2O2 techniques only in these at high-risk rooms.
However, further studies are needed to evaluate such a
strategy.
Our study has some limitations. First, the number of
rooms contaminated with MDRO was relatively small.
As a consequence, no definite conclusion could be
drawn on the comparison of the efficiency of different
H2O2 generators in MDRO environmental disinfection.
However, this comparison was a secondary outcome.
Second, it is important to highlight that the H2O2 gener-
ators used different approaches and different chemical
compositions (30% of H2O2 for HPV versus 7% of H2O2,
30% of acetic acid, and 0.25% of peracetic acid for
aHPP). Third, no definite conclusion could be drawn on
the efficiency of H2O2 decontamination on different
types of MDRO. A recent study [35] suggested that the
reduction of a commercially available biological indicator
cannot always be extrapolated to other microorganisms,
especially MRSA. The production of catalase, which
could break down the H2O2, might result in a reduction
of the effectiveness of these techniques. However, another
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tion, whereas aHP generally achieved less than a 4-log
reduction on the biological indicators and in-house pre-
pared test discs containing approximately 106 MRSA, C.
difficile and A. baumannii [33]. Fourth, this study is
merely environmental and the impact of H2O2 decontam-
ination on the incidence of MDRO colonization or infec-
tion was not studied. Finally, our study was conducted in
a single institution. Therefore, our results may not be
generalizable to other institutions with different infection
control practices and rates of MDRO.
Conclusions
Routine terminal cleaning followed by H2O2 treatment
is more efficient than routine terminal cleaning alone for
disinfection of MDRO contaminated rooms in the ICU.
No significant difference was found between aHPP and
HPV regarding efficiency in disinfection of MDRO con-
taminated rooms. Further studies are needed to evaluate
the toxicity of aHPP techniques.
Key messages
 Hydrogen peroxide techniques are efficient in
disinfecting ICU rooms contaminated with MDRO.
 No significant difference was found between aHPP
and HPV regarding their disinfection efficiency.
 Further studies are needed to evaluate the toxicity of
aHPP.
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